| Factor Information | |
|---|---|
| Data ID | 2765 |
| Factor | Total homocysteine, umol/l |
| Description | Total homocysteine is higher in case mothers than in controls (10.8 vs. 10.2 mmol l-1), which confirms our previously demonstrated association in a subset of these mothers. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | We examined whether maternal lipid levels are associated with the risk of CHD offspring. |
| p Value | <0.05 |
| Conclusion | Total homocysteine is higher in case mothers than in controls (10.8 vs. 10.2 mmol l-1), which confirms our previously demonstrated association in a subset of these mothers. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 21186113 |
| Year | 2012 |
| Title | A derangement of the maternal lipid profile is associated with an elevated risk of congenital heart disease in the offspring |
| Sample | ||
|---|---|---|
| Population | mothers of children with and without CHD | |
| Source | a case-control study | |
| Region | Rotterdam, The Netherlands | |
| Method | Demographics | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD group(Treatment) | Control group(Control) |
| Number | 210 | 284 |
| Age | 33.1 (25.3-41.5) years | 32.6 (24.5-39.8) years |
| Gender (Male: Female) | 0:210 | 0:284 |
| Marker Level | 10.8 (6.9-19.6) umol/l | 10.2 (6.4-16.8) umol/l |
